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Receptor protein tyrosine phosphatase α activates Src-family
kinases and controls integrin-mediated responses in fibroblasts
Jing Su*, Madhavi Muranjan and Jan Sap
Background: Fyn and c-Src are two of the most widely expressed Src-family
kinases. Both are strongly implicated in the control of cytoskeletal organization
and in the generation of integrin-dependent signalling responses in fibroblasts.
These proteins are representative of a large family of tyrosine kinases, the
activity of which is tightly controlled by inhibitory phosphorylation of a carboxy-
terminal tyrosine residue (Tyr527 in chicken c-Src); this phosphorylation
induces the kinases to form an inactive conformation. Whereas the identity of
such inhibitory Tyr527 kinases has been well established, no corresponding
phosphatases have been identified that, under physiological conditions,
function as positive regulators of c-Src and Fyn in fibroblasts. 
Results: Receptor protein tyrosine phosphatase α (RPTPα) was inactivated by
homologous recombination. Fibroblasts derived from these RPTPα–/– mice had
impaired tyrosine kinase activity of both c-Src and Fyn, and this was
accompanied by a concomitant increase in c-Src Tyr527 phosphorylation.
RPTPα–/– fibroblasts also showed a reduction in the rate of spreading on
fibronectin substrates, a trait that is a phenocopy of the effect of inactivation of
the c-src gene. In response to adhesion on a fibronectin substrate, RPTPα–/–
fibroblasts also exhibited characteristic deficiencies in integrin-mediated
signalling responses, such as decreased tyrosine phosphorylation of the c-Src
substrates Fak and p130cas, and reduced activation of extracellular signal
regulated (Erk) MAP kinases. 
Conclusions: These observations demonstrate that RPTPα functions as a
physiological upstream activator of Src-family kinases in fibroblasts and establish
this tyrosine phosphatase as a newly identified regulator of integrin signalling. 
Background
Genetic inactivation of c-Src or Fyn, or transformation by
v-Src — a gain-of-function mutation — affect cell adher-
ence and cytoskeletal organization; these effects correlate
with altered levels of tyrosine phosphorylation of proteins
thought to mediate integrin signalling or control
cytoskeletal architecture [1–3]. Src-family kinases clearly
mediate integrin-dependent adhesive responses [4–8]
because, during cell attachment on fibronectin matrices,
c-Src is required for normal cell spreading [9], whereas
Fyn is required for extracellular signal regulated kinase
(Erk) activation [10]. 
A key mechanism controlling the activity of Src-family
kinases is the reversible phosphorylation of a carboxy-
terminal tyrosine residue — Tyr527 in chicken c-Src —that
is characteristic of this enzyme family. This phosphoryl-
ation event, which is mediated by separate kinases (such as
Csk and Chk [11,12]), favours the adoption of a conforma-
tional state associated with reduced catalytic activity,
increased detergent solubility, and altered intracellular
localization. Loss of this phosphorylation-based inhibitory
switch, for example, by deletion or mutation of the Tyr527
phosphorylation site, is a common mechanism that leads to
oncogenic activation of c-Src [13]. Conversely, dephospho-
rylation of Tyr527 by a specific protein tyrosine phos-
phatase (PTPase) may be a mechanism favouring the
adoption of the ‘open’ kinase-active state. Such a mecha-
nism appears to account for the requirement for the
PTPase CD45 in antigen-receptor signalling pathways
involving Lck and Fyn in lymphocytes [14,15]. CD45 may
function in a different manner with respect to other
Src-family kinases in macrophages, however [16]. 
RPTPα is a widely expressed transmembrane receptor
protein tyrosine phosphatase [17] that can dephosphory-
late Tyr527 of c-Src in vitro, and that can lead to increased
c-Src kinase activity and transformation when overex-
pressed [18,19]. It has also been reported that RPTPα
overexpression can modulate cell adhesion [20,21]. By
relying on drastic overexpression, however, such studies
have failed to provide reliable insight into the role of
endogenous RPTPα in these processes or in signalling
pathways involving the normal function of Src-family
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kinases. A deficiency in the kinase Csk can be partly
rescued by null mutations of c-Src, thus firmly establish-
ing the epistatic relationship between c-Src and its
upstream modulator Csk [1]. By contrast, no definite func-
tional link has thus far been apparent between c-Src and
individual members of the PTPase family. We reasoned
that the criteria for the identification of the phosphatase
that acts as a physiological upstream activator of c-Src in a
particular lineage or process would be twofold. First, dele-
tion of the phosphatase should cause decreased c-Src cat-
alytic activity. Second (and most importantly), loss of the
PTPase should generate a phenotype that mimics, or at
least has some characteristics in common with, that result-
ing from a null mutation of c-Src. We therefore used
homologous recombination in mouse embryonic stem
(ES) cells to generate a null allele at the RPTPα locus.
The phenotype observed in RPTPα–/– fibroblasts derived
from these mice included impaired c-Src and Fyn kinase
activity and reduced cellular responses to adhesion on
fibronectin, consistent with RPTPα acting as an upstream
activator of Src-family kinases during this process.
Results
A β-galactosidase–neomycin-resistance (β-geo) fusion
gene, preceded by an internal ribosomal entry site (IRES),
was introduced into exon 3 (corresponding to the RPTPα
extracellular domain) of the mouse RPTPα locus by
homologous recombination (Figure 1a,b). Homozygous
RPTPα mutant progeny were born in accordance with
expected Mendelian ratios (data not shown). RNA analy-
sis, using a probe corresponding to the region encoding
the RPTPα membrane-proximal phosphatase domain,
revealed no detectable levels of RPTPα mRNA in
homozygous mutant embryonic fibroblasts (Figure 1c).
Furthermore, protein analysis, using a battery of anti-
bodies to various domains in the RPTPα protein, failed to
detect any cross-reactive protein species in various tissues
and cells from homozygous mutant animals, demonstrat-
ing the generation of a null allele (Figure 1d). This analy-
sis also failed to detect evidence for the secretion of a
small soluble RPTPα extracellular-domain fragment that
might still be produced from the mutant locus upstream of
the insertion site (data not shown). RPTPα–/– animals sur-
vived to adulthood and were fertile, but displayed gender-
specific changes in body size, as well as nurturing defects.
A full and detailed characterization of these whole-animal
phenotypes will be reported at a later date. 
To characterize the effects of RPTPα gene inactivation,
we performed in vitro kinase activity measurements of
c-Src and Fyn proteins immunoprecipitated from
explanted, exponentially growing, primary fibroblasts
derived from wild-type mice (+/+), RPTPα+/– heterozy-
gous mice, or RPTPα–/– homozygous mice. These experi-
ments revealed dose-dependent control of the activity of
these kinases by RPTPα: the activities of c-Src and Fyn
towards enolase —provided as an exogenous substrate —
were reduced by 70% and 60%, respectively, in RPTPα–/–
cells compared with wild-type cells (Figure 2a–c). This
change in activity occurred in the absence of changes in
c-Src or Fyn protein levels (Figure 2a). The c-Src kinase
deficiency in cells derived from RPTPα–/– embryos was
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Figure 1
Generation of an RPTPα null allele by gene targeting. (a) Schematic
representation of the targeting vector and the structure of the wild-
type (WT) RPTPα locus surrounding exons 2 and 3 [38] before
(top) and after (bottom) homologous recombination. β-geo,
β-galactosidase–neomycin-resistance fusion gene [39]; B, BamHI;
H, HindIII; P, PstI; R, EcoRI; V, EcoRV; IRES, internal ribosomal
entry site. The regions detected by probes F, G and IRES are also
indicated. (b) Genotyping of wild-type (+/+), heterozygous
RPTPα+/– (+/–), and homozygous RPTPα–/– (–/–) mice by Southern
hybridization using probes F, G, or IRES. (c) Northern hybridization
of RNA from embryonic fibroblasts derived from RPTPα+/+ or
RPTPα–/– embryos, using as probe a 0.7 kb XbaI fragment
corresponding to the membrane-proximal PTPase domain of RPTPα.
The 3 kb RPTPα mRNA is indicated. (d) Absence of RPTPα protein
from RPTPα–/– mouse brain. Mouse brain lysates derived from
RPTPα+/+ or RPTPα–/– animals were subjected to
immunoprecipitation followed by immunoblotting using various
combinations of antibodies recognizing different domains in RPTPα.
The domains recognized by each antibody are as follows: 443, the
entire intracellular domain; 2F8, the ectodomain; and 35, the
carboxyl terminus. The 130 kDa RPTPα protein is indicated.
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rescued by reintroduction of exogenous RPTPα
(Figure 2d), and rescue of c-Src kinase activity by RPTPα
was dependent on the dimerization state of the RPTPα
protein (G. Jiang, J. den Hertog, J. Su, J. Noel, J. Sap, and
T. Hunter, unpublished observations). Reduced c-Src
kinase activity was also observed in tissue lysates from
RPTPα–/– animals (data not shown). 
To determine whether the effect of RPTPα ablation on
c-Src kinase activity was associated with changes in phos-
phorylation of Tyr527 in c-Src, we made use of a mono-
clonal antibody, clone 28, that specifically recognizes the
active (non-Tyr527-phosphorylated) form of c-Src. This
antibody recognizes the motif surrounding Tyr527 in a
manner that is hindered by phosphorylation of Tyr527
[22]. Equal amounts of lysate from exponentially growing
wild-type or RPTPα–/– cells were subjected to immuno-
precipitation with antibody 327, which recognizes an
epitope in the Src homology 3 (SH3) domain of c-Src. The
immunoprecipitate was subsequently halved and each half
immunoblotted either with antibody 327 (as a control to
normalize for the total amount of c-Src protein), or with
clone 28. These experiments revealed a higher reactivity
of c-Src with the activation-specific antibody (clone 28) in
wild-type cells compared with their RPTPα–/– counter-
parts (Figure 2e). Higher reactivity to clone 28 in wild-
type cells compared with RPTPα–/– cells was also observed
in total cell lysates during short-term adhesion assays on
fibronectin (Figure 2f). 
c-Src–/– fibroblasts have previously been shown to display a
delay in adhesion-dependent spreading on fibronectin-
coated substrates [9]. This effect can be rescued by
kinase-negative versions of c-Src, demonstrating that
physiological c-Src functions rely on adaptor-like mecha-
nisms as well as on kinase activity. We explored whether
c-Src and RPTPα might be linked in a common signalling
cascade by determining whether the absence of RPTPα
would mimic the fibroblast-spreading-deficiency pheno-
type characteristic of c-Src ablation [9]. Lack of RPTPα
did not affect the efficiency of cell attachment to a
fibronectin-coated surface (data not shown), suggesting
that the integrin-adhesive function per se was not
detectably affected. By contrast, following the attachment
phase, RPTPα–/– cells displayed a clear but transient delay
in cell spreading, which was most prominent between
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Figure 2
RPTPα gene dosage affects c-Src and Fyn
kinase activity in fibroblasts. The (a,b) c-Src
or (c) Fyn proteins were immunoprecipitated
from cells of the indicated genotypes at the
RPTPα locus and their activity was assayed
by measuring the amount of 32P
incorporated into an exogenous substrate
(enolase) in vitro. (a) Autoradiograph of a
typical c-Src in vitro kinase assay, showing
the incorporation into enolase, as well as
autophosphorylation of c-Src (top panel),
and a control anti-c-Src immunoblot of an
aliquot of the immunoprecipitate (bottom
panel) to show that equal amounts of protein
were used in each assay. (b) Quantitation of
c-Src kinase activity. Bars represent the
average ± standard error (SE) of three
separate experiments. (c) Quantitation of
Fyn kinase activity. Bars represent the
average ± SE of four separate experiments.
Data in (a–c) were confirmed using several
independently isolated primary or
established fibroblast cultures.
(d) Restoration of c-Src kinase activity by
reintroduction of RPTPα into RPTPα–/–
fibroblasts. RPTPα–/– cells were transfected
with empty vector (control) or an RPTPα
expression plasmid, and individual clones
assayed for c-Src activity using the in vitro
kinase reaction described in (a–c). Data are
an average of three clones for cells
transfected with control vector and two for
the RPTPα-expressing clones. In (b–d) the
c-Src or Fyn kinase activity in RPTPα+/+
cells was taken as 1. (e,f) Difference in
reactivity of c-Src protein from primary wild-
type (+/+) and RPTPα–/– (–/–) fibroblast
cells to an antibody (clone 28) specific for
the Tyr527-dephosphorylated (active) form
of Src. (e) c-Src protein was precipitated
from equal amounts of lysate from the
respective cycling cells, using an antibody
(327) against the SH3 domain of Src; the
precipitate was then halved and each half
immunoblotted with either clone 28 (top) or
clone 327 (bottom) antibodies. The
increased reactivity to clone 28 in RPTPα+/+
cells compared with RPTPα–/– cells
averaged 1.7 (as revealed by densitometry)
over four experiments, performed with
different pairs of primary cells or established
lines. (f) Equal amounts of total lysate from
wild-type (+/+) or RPTPα–/– (–/–) primary
fibroblasts allowed to adhere for 15 min on a
fibronectin-coated surface were subjected to
immunoblotting with clone 28 (top) or clone
327 (bottom) antibodies.
+/+ –/–
(a) (b) (c)
–/–+/+ +/–
(d) (e) (f)
Enolase
c-Src
c-Src
IgG
c-
S
rc
 k
in
as
e 
ac
tiv
ity
+/+ +/– –/–
Fy
n 
ki
na
se
 a
ct
iv
ity
+/+ –/–
Blot: 28
Blot: 327
Blot: 28
Blot: 327
0
0.5
1
1.5
c-
S
rc
 k
in
as
e 
ac
tiv
ity
+/+ –/– –/–
+/+ –/–
FibronectinCycling
Control RPTPα
Kinase
activity:
Blot:
Current Biology   
0.00
0.25
0.50
0.75
1.00
1.25
0.00
0.25
0.50
0.75
1.00
1.25
10 and 20 minutes (Figure 3a,b), similar to that reported
for c-src gene ablation [9]. In a rescue experiment, infec-
tion of RPTPα–/– cells with an RPTPα-expressing retro-
virus (but not with a control virus) enhanced the spreading
rate (Figure 3c), supporting the notion that the spreading
deficit in RPTPα–/– cells is reversible, and a relatively
direct result of the lack of RPTPα.
To determine whether deficiencies in proximal integrin-
dependent signal transduction could account for the
reduced spreading rate of RPTPα–/– fibroblasts, we moni-
tored the levels of protein phosphorylation on tyrosine
residues during the spreading process. Anti-phosphotyro-
sine immunoblotting analysis of total cellular lysates pre-
pared at various stages of spreading revealed reduced
tyrosine phosphorylation of proteins in the 130 kDa
(Figure 4a, upper panel) and 40 kDa (Figure 4a, middle
panel) range in cells lacking RPTPα, supporting the
notion that RPTPα functions as an upstream activator of a
tyrosine kinase during this process. Focal adhesion kinase
(Fak), a protein tyrosine kinase, and the Crk-associated
substrate p130cas, a multi-adaptor docking protein, were
both identified as proteins the phosphorylation of which is
markedly enhanced in v-Src-transformed cells; in non-
transformed cells, both proteins are phosphorylated by,
and associate with, c-Src in response to integrin-depen-
dent cell adhesion, probably mediating some of the inte-
grin-dependent events [2–4]. Immunoprecipitation with
the respective specific antibodies revealed reduced tyro-
sine phosphorylation of p130cas and Fak in RPTPα–/– cells,
consistent with impaired c-Src function (Figure 4b,c).
Concomitant with tyrosine kinase activation, integrin-
dependent fibroblast responses also include activation of
the Erk arm of the mitogen-activated protein (MAP)
kinase cascade [5,7], either through recruitment of the
Grb2 adaptor to Fak–c-Src complexes [8,23], or through
Fyn-mediated tyrosine phosphorylation of the adaptor
protein Shc [10,24]. In accordance with this, attachment
and spreading of wild-type fibroblasts on a fibronectin
substrate was accompanied by enhanced Erk activity, as
assessed by phosphorylation of exogenously supplied
myelin basic protein (MBP) in anti-Erk immunoprecipi-
tates. By contrast, Erk activation was significantly reduced
as a consequence of RPTPα ablation (Figure 4d,e). 
Discussion
Although we cannot exclude additional mechanisms —
such as the involvement of an intermediate phosphatase, a
role for RPTPα in regulating Csk, or the ability of other
PTPases to contribute to the control of c-Src tyrosine
phosphorylation or activity [25–28] — the most economic
interpretation of our observations is that RPTPα directly
dephosphorylates c-Src Tyr527 in vivo, consistent with its
ability to do so in vitro [18,19]. This dephosphorylation
event would then either initiate, or maintain, the open
conformation of c-Src. Such a direct relationship would
also be consistent with the reported association of RPTPα
with c-Src or Fyn [21,29]. We propose that our observa-
tions that RPTPα inactivation reduces c-Src and Fyn
kinase activity, while also generating a phenocopy of c-Src
ablation in fibroblasts, strongly suggest that this phos-
phatase acts as a physiological upstream regulator of Src-
family kinases in this lineage. Our data clearly do not,
however, rule out the possible existence of additional
targets for RPTPα. 
The control of c-Src function by RPTPα is reminiscent of
the contribution of CD45 towards Lck or Fyn activity in
lymphocytes [30], but contrasts with the apparent nega-
tive control of Src-family kinase function by CD45 in
macrophages [16]. The cytosolic PTPase SHP-1 has been
implicated in the activation of c-Src in platelets and thy-
mocytes [25], although it may also inactivate the Src-
family kinases Lck and Fyn [26]. The PTPase SHP-2 has
been shown to associate with c-Src in fibroblasts and
HT-29 colon carcinoma cells, and to be capable of dephos-
phorylating Tyr527 in vitro [27]. Intriguingly, SHP-2–/–
fibroblasts display a phenotype very similar to that of
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Figure 3
RPTPα ablation delays the integrin-mediated
cell spreading response of fibroblasts.
(a) RPTPα+/+ and RPTPα–/– cells 15 min after
plating onto fibronectin-coated surfaces.
(b) RPTPα+/+ and RPTPα–/– cells were
allowed to adhere for 15 min to bovine serum
albumin (BSA)- or fibronectin-coated surfaces,
and cell spreading expressed as a fraction of
total adherent cells. (c) Accelerated RPTPα–/–
cell spreading upon reintroduction of wild-type
RPTPα. RPTPα–/– cells were infected with a
retrovirus expressing RPTPα or with empty
control vector and cell spreading was
monitored over time after plating onto a
fibronectin-coated surface. 
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RPTPα–/– cells, that is, delayed spreading on fibronectin-
coated substrates, and impaired activation of integrin-
induced signalling events such as activation of Src-family
kinases, phosphorylation of focal adhesion proteins, and
Erk activation [28,31]. The involvement of both RPTPα
and SHP-2 in the regulation of c-Src activity and in fibro-
blast spreading clearly calls for a more precise dissection of
the specific roles of these two phosphatases in integrin sig-
nalling, and in the complex processes that constitute focal
adhesion formation and turnover, and cytoskeletal remod-
elling. One range of possibilities may involve both
PTPases independently (possibly directly) controlling Src
Tyr527 phosphorylation levels. Under such a scenario,
both would be essential, as a result of, for instance, their
abilities to act on different Src populations, in different
intracellular locations, or at a different stage of the spread-
ing process. Fibroblast adhesion is indeed known to
involve a c-Src translocation event [9]. Alternatively,
SHP-2 and RPTPα may act sequentially (but not neces-
sarily in this order), with only one of these PTPases (or
possibly even yet another PTPase) directly dephosphory-
lating Tyr527. In this case, regulatory interactions
between RPTPα and SHP-2 must be postulated, and
these might involve direct dephosphorylation of one
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Figure 4
Effect of RPTPα deletion on phosphorylation
events following adhesion on fibronectin.
(a) Equal amounts of protein lysates derived
from wild-type (+/+), RPTPα+/– (+/–) and
RPTPα–/– (–/–) fibroblasts, prepared at
various times after adhesion to a fibronectin
substrate, as indicated, were analyzed by anti-
phosphotyrosine (P-Tyr; top and middle
panels) or anti-Erk (lower panel)
immunoblotting. (b) Anti-Fak and (c) anti-
p130cas immunoprecipitates from cells in
suspension or cells allowed to adhere on
fibronectin for 20 min were analyzed by
immunoblotting with anti-phosphotyrosine
antibodies (top panels) or, as control, with the
respective p130cas or Fak antisera (bottom
panels). (d) Anti-Erk immune complexes,
prepared from cells in suspension or cells
allowed to adhere on fibronectin for 15 min,
were halved, with one half being subjected to
an in vitro Erk kinase reaction using myelin
basic protein (MBP) as substrate (top panel),
and the other half to anti-Erk immunoblotting
(lower panel). (e) The Erk activities from three
independent experiments such as those
presented in (d) were quantitated and are
shown as the average ± SE. 
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PTPase by the other, or more indirect mechanisms involv-
ing intermediate proteins. At any rate, the positive roles of
RPTPα and SHP-2 contrast with the recently proposed
negative role of the tumor suppressor PTEN in cell
spreading and in signalling responses downstream of inte-
grin engagement by extracellular matrix molecules
[32,33]. Fibroblasts lacking the PTPase PTP-PEST were
also recently shown to display enhanced spreading rates
when plated on fibronectin, together with enhanced tyro-
sine phosphorylation of Fak and p130cas [34].
An additional consequence of c-Src ablation in mice is
osteopetrosis due to a functional deficit in the osteoclast
lineage [35,36]. X-ray analysis of RPTPα–/– mice up to
9 month old has thus far failed to detect signs of osteopet-
rosis (data not shown). This apparent paradox may
suggest that, in osteoclasts, the role of RPTPα in c-Src
function is performed by other PTPases. For instance,
RPTPε, the PTPase most similar to RPTPα, displays a
much more restricted expression pattern than RPTPα,
but is actually abundant in differentiated osteoclasts [37].
Similarly, in T lymphocytes, activation of Fyn has been
suggested to be largely mediated by the PTPase CD45
[14]. By analogy, phosphorylation of Tyr527 in c-Src can
be mediated by at least two kinases with different expres-
sion patterns, Csk and Chk [11,12]. Alternatively, given
the large number of processes in which c-Src has been
implicated [6,7], the requirement for RPTPα in c-Src
function may be stimulus-specific, indicating that fibrob-
last spreading on fibronectin and bone resorption by
osteoclasts involve different regulators of c-Src. Taken
together, these considerations suggest a testable model, in
which coupling between particular PTPases and Src-
family kinases may convey a measure of cell- and stimu-
lus-specificity to signalling pathways. 
Materials and methods
Homologous recombination
A replacement-type targeting vector, consisting of an IRES–β-geo cas-
sette [38] (I. Chambers, Edinburgh) inserted at a PstI site present in
exon 3 of the mouse RPTPα locus [39], was electroporated into the
mouse ES cell line W4 (A. Joyner, NYU). Positive clones were identi-
fied by Southern hybridization, chimeric founders mated with 129SvJ
animals, and the mutated allele maintained on this background.
Immunoprecipitations and antibodies
Cells were lysed in RIPA buffer (50 mM HEPES pH 7.4, 1% deoxy-
cholate, 1% Triton X-100, 0.1% SDS, 150 mM NaCl, 1 mM EDTA,
1 mM Na3VO4) containing 1 mM phenylmethylsulfonyl fluoride (PMSF),
10 µg/ml leupeptin and 10 µg/ml aprotinin. Equal amounts of protein
from cleared extracts were subjected to standard immunoprecipitation
or immunoblotting procedures. Antibodies used were: clone 327
against c-Src (Oncogene Science); anti-Erk 1 and 2 (Santa Cruz);
F15020 (Transduction Laboratories) against Fak; antiserum B against
p130cas (T. Parsons, University of Virginia); anti-phosphotyrosine anti-
body 4G10 (Upstate Biotechnology); anti-RPTPα 443 and 35, raised
against the entire RPTPα intracellular domain or a carboxy-terminal
peptide, respectively; antibody 2F8, against the RPTPα ectodomain,
was a gift from M. Thomas (Washington University, St. Louis); clone 28
antibody was most generously donated by H. Kawakatsu (UCSF).
Src and Fyn kinase assays
Immune complexes of c-Src or Fyn were washed three times with RIPA
lysis buffer followed by two washes with kinase buffer (20 mM PIPES
pH 7.0, 5 mM MnCl2), and reacted in a volume of 50 µl kinase buffer
containing 5 µCi [γ-32P]ATP and 12.5 µg acid-denatured enolase at
30°C for 5 min. After electrophoresis, phosphorylation of enolase was
quantified with a Phosphor-Imager (Molecular Dynamics).
Erk assay 
Triton-buffer lysates were subjected to immunoprecipitation with anti-
Erk 1 and 2 antisera, and the immune complexes washed twice with
lysis buffer and twice with kinase buffer (10 mM Tris pH 7.4, 10 mM
MgCl2). An in vitro kinase reaction was performed in 50 µl kinase
buffer containing 5 µCi [γ-32P]ATP and 12.5 µg MBP. After incubation
for 30 min at 30°C, the reaction was stopped by boiling in SDS–PAGE
sample buffer, and the reaction products separated by SDS–PAGE.
The radioactive content of 32P-labeled MBP was determined using
liquid scintillation counting.
Cell culture
Primary embryonic fibroblasts were isolated from E13–E15 day old
embryos, with RPTPα+/+ and RPTPα–/– embryos and cells always
being derived in parallel from the same pregnancy. Cells were cultured
in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with
10% fetal calf serum. For spontaneous immortalization, cells were
trypsinized and reseeded every 3 days at a density of 106/100 mm dish
until crisis had been overcome. Alternatively, a retroviral vector express-
ing polyoma large T antigen was used to immortalize the cultures. All
experiments shown were performed on several independently isolated
lines as well as on primary isolates. For reintroduction of RPTPα, an
RPTPα–/– culture was infected as a pool with an RPTPα-expressing or
control retrovirus. Quantitative infection was established by fluores-
cence of a green fluorescent protein (GFP) marker coexpressed from
the same vector. 
Cell spreading 
Cells were trypsinized briefly, and the digestion stopped using
0.5 mg/ml trypsin inhibitor (Gibco). They were then resuspended
(125,000 cells/ml) in DMEM, and plated in 4 ml adhesion medium on
6 cm tissue-culture dishes coated with fibronectin (5 µg/ml of human
fibronectin (Gibco) overnight at 4°C). Plates were incubated at 37°C
for the designated periods of time, chilled on ice for 15 min, and five
microscope fields were photographed and counted. 
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